General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry
General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry guidance is intended to assist sponsors of investigational new…
Read more →FDA Regional Implementation Guide for E2B(R3) Electronic Transmission of Individual Case Safety Reports for Drug and Biological Products
FDA Regional Implementation Guide for E2B(R3) Electronic Transmission of Individual Case Safety Reports for Drug and Biological Products technical specifications document is to assist…
Read more →Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential-Questions and Answers
Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential-Questions and Answers question-and-answer (Q&A) document is intended to clarify key issues to facilitate…
Read more →Submitting Documents Using Real-World Data and Real-World Evidence to FDA for Drug and Biological Products
Submitting Documents Using Real-World Data and Real-World Evidence to FDA for Drug and Biological Products guidance applies to submissions for investigational new drug applications…
Read more →Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment
Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment this guidance is to assist sponsors in the clinical development of drugs and biological…
Read more →REMS Document Technical Conformance Guide
REMS Document Technical Conformance Guide provides updated, detailed instructions on the format of a REMS Document, along with standardized language that describes common REMS…
Read more →